Macrolide-resistant Bordetella pertussis strain identified during an ongoing epidemic, Finland, January to October 2024
2024

Macrolide-resistant Bordetella pertussis strain identified in Finland

Sample size: 2215 publication Evidence: high

Author Information

Author(s): Miettinen Milja, Barkoff Alex-Mikael, Nyqvist Aino, Savolainen-Kopra Carita, Antikainen Jenni, Mertsola Jussi, Ivaska Lauri, He Qiushui

Primary Institution: Finnish Reference Laboratory for Diphtheria and Pertussis, University of Turku

Hypothesis

The study investigates the emergence of macrolide-resistant Bordetella pertussis during an ongoing epidemic in Finland.

Conclusion

The study identified the first macrolide-resistant Bordetella pertussis isolate in Finland, highlighting the need for rapid detection and surveillance.

Supporting Evidence

  • There were 2,215 notified cases of pertussis in Finland from January to October 2024.
  • 30.1% of the cases were in adolescents aged 10-14 years.
  • One Bordetella pertussis isolate was found to be macrolide-resistant with a minimum inhibitory concentration greater than 256 μg/mL.

Takeaway

There is a new type of whooping cough bacteria in Finland that doesn't respond to some common medicines, and it's important to find it quickly.

Methodology

The study involved characterizing Bordetella pertussis isolates from an ongoing epidemic and testing for macrolide resistance using Etest and PCR methods.

Limitations

The study lacks clinical information about the patient from whom the resistant isolate was obtained.

Participant Demographics

The majority of cases were among adolescents aged 10-14 years, with a notable number of cases in younger children and infants.

Digital Object Identifier (DOI)

10.2807/1560-7917.ES.2024.29.49.2400765

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication